Centene director Samuels buys $248k in company stock

Published 29/07/2025, 23:14
Centene director Samuels buys $248k in company stock

Director Theodore R. Samuels II of CENTENE: CNC, recently purchased 9,000 shares of Centene (NYSE:CNC) Corp. common stock at $27.62, for a total transaction value of $248,580. The purchase comes as the stock trades near its 52-week low of $25.50, having declined over 57% year-to-date. According to InvestingPro analysis, the stock appears undervalued, with management actively buying back shares.

Following the transaction on July 28, 2025, Samuels directly owns 18,494.979 shares of common stock, which includes 3,579 shares of restricted stock units subject to vesting requirements. He also indirectly owns 32,000 shares through a family trust for which he serves as co-trustee. With the stock showing oversold conditions, InvestingPro offers 14 additional investment tips and a comprehensive analysis report for CNC.

Samuels also holds options to purchase 10,000 shares of Centene common stock at an exercise price of $80.57, which became exercisable on February 7, 2025, and expire on February 7, 2032.

In other recent news, Centene Corporation reported its Q2 2025 financial results, revealing a notable earnings miss. The company posted an adjusted loss per share of $0.16, falling short of the anticipated earnings per share of $0.23. Despite this, Centene experienced a boost in its stock due to strong revenue performance and a positive outlook for future profitability. Additionally, Cantor Fitzgerald downgraded Centene’s stock rating from Overweight to Neutral. The downgrade was attributed to macro uncertainty in the Health Insurance Exchange and Medicaid markets, particularly concerning Centene’s earnings exposure to the HIX segment. Meanwhile, eHealth (NASDAQ:EHTH), Inc. announced the appointment of Derrick Duke as its new Chief Executive Officer, effective September 18, 2025. Duke will succeed Fran Soistman, who is retiring but will remain on the Board of Directors and continue as an executive advisor through the end of the year. These developments highlight significant leadership changes and financial assessments within the health insurance sector.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.